Clinical Trial Update: Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated the safety and tolerability of sub-retinal transplantation of MA09-hRPE cells derived from human embryonic stem cells in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration

Drugs mentioned

• MA09-hRPE (human embryonic stem cell-derived retinal pigment epithelium cells)

Snippet

Sponsor: Astellas Institute for Regenerative Medicine | Conditions: Dry Age Related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED